|
End-of-day quote
Shenzhen S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 4.270 CNY | -1.84% |
|
+3.39% | -5.53% |
| Market Cap | 2.92B 433M 374M 352M 320M 601M 41.41B 611M 4.12B 1.61B 20.74B 1.63B 1.59B 68.92B | P/E 2024 |
-2.74x | P/E 2025 | -7.41x |
|---|---|---|---|---|---|
| Enterprise Value | 3.33B 494M 427M 401M 365M 686M 47.25B 697M 4.7B 1.84B 23.66B 1.86B 1.81B 78.63B | EV / Sales 2024 |
2.87x | EV / Sales 2025 | 3.89x |
| Free-Float |
54.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.84% | ||
| 1 week | +3.39% | ||
| Current month | +22.00% | ||
| 1 month | +18.94% | ||
| 3 months | -11.04% | ||
| 6 months | +1.43% | ||
| Current year | -5.53% |
| 1 week | 4.05 | 4.53 | |
| 1 month | 3.18 | 4.53 | |
| Current year | 3.18 | 5.26 | |
| 1 year | 3.18 | 5.45 | |
| 3 years | 1.24 | 6.09 | |
| 5 years | 1.24 | 7.83 | |
| 10 years | 1.24 | 31.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Zhang
CEO | Chief Executive Officer | 59 | 2010-02-28 |
| Director of Finance/CFO | 52 | 2023-04-20 | |
Wei He
CTO | Chief Tech/Sci/R&D Officer | 49 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Lan Zhang
BRD | Director/Board Member | 54 | 2019-09-26 |
Xiao You Zhang
BRD | Director/Board Member | 74 | - |
You Guang Li
BRD | Director/Board Member | 69 | 2019-09-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.84% | +3.39% | -14.94% | +9.77% | 441M | ||
| -2.25% | -0.47% | +72.43% | +119.36% | 1,078B | ||
| -0.66% | +0.43% | +49.01% | +50.11% | 632B | ||
| -0.54% | +1.39% | +21.88% | +63.83% | 443B | ||
| -1.99% | -3.32% | +41.98% | +34.08% | 356B | ||
| -1.05% | -2.81% | +24.22% | +34.67% | 289B | ||
| -2.12% | -3.67% | -1.09% | +3.11% | 245B | ||
| -0.63% | +1.04% | +43.03% | +59.10% | 226B | ||
| -1.19% | -3.41% | -9.18% | -52.41% | 204B | ||
| +0.16% | +3.87% | +16.25% | +73.27% | 171B | ||
| Average | -0.78% | +0.30% | +24.36% | +39.49% | 364.41B | |
| Weighted average by Cap. | -0.08% | +0.31% | +41.44% | +62.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.2B 177M 153M 144M 131M 246M 16.95B 250M 1.69B 659M 8.49B 666M 651M 28.21B | 900M 133M 115M 108M 98.48M 185M 12.76B 188M 1.27B 496M 6.39B 501M 490M 21.23B |
| Net income | -650M -96.39M -83.25M -78.23M -71.15M -134M -9.22B -136M -917M -358M -4.62B -362M -354M -15.34B | -420M -62.22M -53.74M -50.5M -45.93M -86.35M -5.95B -87.77M -592M -231M -2.98B -234M -229M -9.9B |
| Net Debt | 1.66B 246M 213M 200M 182M 342M 23.55B 347M 2.34B 916M 11.8B 925M 905M 39.2B | 412M 61.03M 52.71M 49.53M 45.05M 84.69M 5.84B 86.09M 580M 227M 2.92B 229M 224M 9.71B |
Employees
979
Sector
Pharmaceuticals
Calendar
03:00am
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | CN¥4.270 | -1.84% | 20,876,900 |
| 26-08-13 | CN¥4.350 | -1.36% | 27,773,600 |
| 26-08-12 | CN¥4.410 | +3.28% | 42,594,635 |
| 26-08-11 | CN¥4.270 | -0.93% | 48,121,064 |
| 26-08-10 | CN¥4.310 | +4.36% | 70,262,654 |
- Stock Market
- Stocks
- 002742 Stock
Select your edition
All financial news and data tailored to specific country editions
















